Michaela Liedtke
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Oncology top 1%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 57
- Hematology 84
- Multiple Myeloma Research and Treatments 51
- Acute Myeloid Leukemia Research 23
- Chronic Myeloid Leukemia Treatments 17
- Co-authors
- Ronald Witteles (22 shared papers)Anjali S. Advani (29 shared papers)Daniel J. DeAngelo (20 shared papers)Wendy Stock (25 shared papers)Erik Vandendries (19 shared papers)Hagop M. Kantarjian (16 shared papers)Matthias Stelljes (17 shared papers)Nicola Gökbuget (15 shared papers)
- Journals
- Blood (53 papers)Journal of Clinical Oncology (19 papers)Blood Advances (6 papers)Haematologica (4 papers)British Journal of Haematology (3 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Michaela Liedtke
159 papers receiving 4.9k citations
Michaela Liedtke's Hit Papers
Peers
Comparison fields: 5 of 110
- Hematology 1.7k
- Oncology 2.1k
- Genetics 624
- Nephrology 294
- Public Health, Environmental and Occupational Health 1.2k
Countries citing papers authored by Michaela Liedtke
This map shows the geographic impact of Michaela Liedtke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Liedtke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Liedtke more than expected).
Fields of papers citing papers by Michaela Liedtke
This network shows the impact of papers produced by Michaela Liedtke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Liedtke. The network helps show where Michaela Liedtke may publish in the future.
Co-authors
The 25 scholars most cited alongside Michaela Liedtke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia Hit paper breakdown → | 2016 | 869 |
| 2 | 2019 | 257 | |
| 3 | 2019 | 224 | |
| 4 | 2017 | 179 | |
| 5 | Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results Hit paper breakdown → | 2023 | 168 |
| 6 | 2016 | 147 | |
| 7 | 2013 | 144 | |
| 8 | 1992 | 118 | |
| 9 | 2014 | 111 | |
| 10 | 2013 | 101 | |
| 11 | 2017 | 99 | |
| 12 | 2017 | 93 | |
| 13 | 2015 | 89 | |
| 14 | 2009 | 77 | |
| 15 | 2006 | 71 | |
| 16 | 2021 | 70 | |
| 17 | 2020 | 69 | |
| 18 | 2009 | 64 | |
| 19 | 2011 | 64 | |
| 20 | 2015 | 63 |
About Michaela Liedtke
Michaela Liedtke is a scholar working on Molecular Biology, Hematology, Oncology, Public Health, Environmental and Occupational Health and Genetics, having authored 167 papers that have together received 5.0k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (57 papers), Multiple Myeloma Research and Treatments (51 papers), Acute Lymphoblastic Leukemia research (40 papers), CAR-T cell therapy research (32 papers), Chronic Lymphocytic Leukemia Research (29 papers), Acute Myeloid Leukemia Research (23 papers), Chronic Myeloid Leukemia Treatments (17 papers) and Neuroendocrine Tumor Research Advances (17 papers). The work is most often cited by research in Hematology (1.7k citations), Oncology (2.1k citations), Genetics (624 citations), Nephrology (294 citations) and Public Health, Environmental and Occupational Health (1.2k citations). Michaela Liedtke has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Ronald Witteles, Anjali S. Advani, Daniel J. DeAngelo, Wendy Stock, Erik Vandendries, Hagop M. Kantarjian, Matthias Stelljes, Nicola Gökbuget, Susan O’Brien and Barbara Sleight. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Haematologica and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.